Antithrombolytic and antidiabetic activity of methanolic extract of Paederia foetida

Pharmacognosy Journal

Volumn 4, Issue 30, 2012, Pages 30-33

  Morshed, Helal ^a   Sayeed, Muhammad Shahdaat Bin ^a   Mostofa, A G M ^a   Islam, Md Siddiqul ^a   Parvin, Salma ^a  

^a UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

Antidiabetic activity; Antithrombolytic activity; Methanol extract; Paederia foetida

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; GLIBENCLAMIDE; GLUCOSE; METHANOL; PAEDERIA FOETIDA EXTRACT; PLANT EXTRACT; POLYSORBATE 80; STREPTOKINASE; UNCLASSIFIED DRUG; WATER;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEEDING; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PAEDERIA FOETIDA; RAT; RUBIACEAE;

EID: 84864271097     PISSN: 09753575     EISSN: None     Source Type: Journal    
DOI: 10.5530/pj.2012.30.6     Document Type: Article

References (17)

1. Blatter E, Caius JF, et. al. Indian Medicinal Plants. 1981; 2:1297-1299.
2. Giuseppina B, Cristiana L, Guido L, Piero C, Antonio L, Daniele R. Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. an in vitro study on blood of normal subjects and patients with coronary artery disease. Thromb Haemost. 2004; 91:1078-1083.
3. Bailey CJ and Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care. 1989; 12:553-564.
4. Mitra SK, Gopumadhavan S, Muralidhar TS, Anturlikar SD, Sujatha MB. Effect of a herbomineral preparation D-400 in streptozotocin induced diabetic rats. J Ethnopharmacol. 1996; 54:41-46. (Pubitemid 26379875)
5. Annapurna A, Kanaka, Mahalakshmi D, Murali KK. Antidiabetic activity of a polyherbal preparation (tincture of punchparna) in normal and diabetic rats. Indian J Exp Biol. 2001; 39:500-502. (Pubitemid 32430491)
6. Bhattacharya SK, Satyan KS, Chakrbarti A. Effect of Trasina, an ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J Exp Biol. 1997; 35:297-299. (Pubitemid 28135423)
7. Adams DS, Griffin LA, Nachajko WR, Reddy VB, Wei CM. A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor. J Biol Chem. 1991; 266:8476-8482. (Pubitemid 21906534)
8. Lijnen HR, Vanhoef B, DeCock F, Okada K, Ueshima S, Matsuo O. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem. 1991; 266:11826-11832. (Pubitemid 21907023)
9. Marder VJ. Recombinant streptokinase-opportunity for an improved agent. Blood Coagul Fibrinolysis. 1993; 4:1039-1040.
10. Nicolini FA, Nichols WW, Mehta JL, Saldeen TG, Schofield R, Ross M, et al. Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue plasminogen activator. J Am Coll Cardiol. 1992; 20:228-235.
11. Wu DH, Shi GY, Chuang WJ, Hsu JM, Young KC, Chang CW. Coiled coil region of streptokinase gamma-domain is essential for plasminogen activation. J Biol Chem. 2001; 276:15025-15033.
12. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications, 1999. Report of a WHO Consultation. Geneva; 2003
13. Wild, S., Roglic, G., Sicree, R., Green, A., King, H. Global burden of diabetes mellitus in the year 2000. Global Burden of Disease, Geneva; 2000.
14. Marles, R.J., Farnsworth, N.R. Antidiabetic plants and their active constituents. Phytomedicine. 1995; 2:137-189.
15. The WHO Expert Committee on Diabetes Mellitus. Technical Report Series 646, Geneva and World Health Organisation; 1980.
16. Trease GE, Evans WC. Trease and Evans Pharmacognosy. 13th ed. Philadelphia, Baillire Tindall; 1989.
17. Chattopadhyay RR. Hypoglycemic effect of Ocimum sanctum leaf extract in normal and streptozotocin diabetic rats. Indian Journal of Experimental Biology. 1993; 31:891-893. (Pubitemid 24090854)